is there an alternative to glp 1 FDA Approves Wegovy for Weight Loss, Foundayo Pill GLP-1 Safety Check - National
Description
4 Similarly, in tirzepatides SURMOUNT-1 study, 9-15% lost less than 5% and 16-31% loss less than 10% (dose-dependent)
Nutrition Research
PMID 3543057
The life expectancy of people with T2D is reduced due to increased mortality from cardiovascular disease (CVD)
This review addresses the promising landscape of GLP-1 RAs to treat persons with overweight or obesity, with or without T2DM, within the context of CKD, assessing their safety and impact on weight, metabolic control, blood pressure and kidney and cardiovascular outcomes, as part of a holistic patient-centred approach to preserve CKM health
